glp 1 help with inflammation Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits Central glucagon-like peptide 1 receptor

Leptin was supposed to be the magic bullet when it was first discovered

Tolhurst, G., Heffron, H., Lam, Y

Headaches occur with both medications

You may have a higher risk of eye-related side effects if you have: Existing eye conditions, especially diabetic retinopathy Diabetes-related eye disease High blood pressure High cholesterol Sleep apnea These conditions may also have an impact on vision, which makes it difficult to fully understand the impact of GLP-1 medications, says Dr

It contains the same drug at the same doses, so theres no clinical difference between the two

But as evidence propositions they are worlds apart: one is an FDA-approved drug with replicated Phase 3 trials, the other is an unapproved research chemical with two small surrogate-marker studies and discontinued development